Humacyte, Inc.

NasdaqGS: HUMA · Healthcare

Positivity Index

#5,469 / 6,774

Global

#2,980 / 4,000

United States

Positivity Score

17,290

Rank→

PosiRed: 2 active red flags (highest severity 6/10) View flag history →

PosiRed · red flag

Stock exchange listing-rule deficiency notice (8-K Item 3.01)

The company reported in a Form 8-K (Item 3.01) filed on 31 Jul 2026 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.

More details →

PosiRed · red flag

Stock exchange listing-rule deficiency notice (8-K Item 3.01)

The company reported in a Form 8-K (Item 3.01) filed on 08 May 2026 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.

More details →

Humacyte, Inc. — Overview & Financial Snapshot

Humacyte, Inc. (NasdaqGS: HUMA) is a Healthcare company, ranked #5,469 of 6,774 companies globally and #2,980 of 4,000 in United States on PositoAI, with a Positivity Score of 17,290. Its market capitalisation is ₹1,083.21 Cr ($114.76M), P/E ratio is -0.8 and P/B ratio is 3.67. It currently has 2 active red flags (PosiRed) and no yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →

What does Humacyte, Inc. do?

Humacyte, Inc., together with its subsidiaries, engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific…

What is Humacyte, Inc.'s P/E and P/B ratio?

Humacyte, Inc. has a P/E ratio of -0.8 and a P/B ratio of 3.67.

What is Humacyte, Inc.'s debt-to-equity ratio?

Humacyte, Inc. has a debt-to-equity ratio of 2.14.

How much does Humacyte, Inc. owe compared with what it owns?

Humacyte, Inc. owes $0.77 for every $1 it owns (balance sheet Jun 2026), which is moderate.

What is Humacyte, Inc.'s Positivity rank?

Humacyte, Inc. is ranked #5,469 of 6,774 companies globally and #2,980 of 4,000 in United States on PositoAI, with a Positivity Score of 17,290.

Does Humacyte, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

Yes. Humacyte, Inc. has 2 active red flags (PosiRed) on record: Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 31 Jul 2026); Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 08 May 2026). It has no yellow flags.

Where can I read the latest news about Humacyte, Inc.?

Recent headlines about Humacyte, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does Humacyte, Inc. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of Humacyte, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.